Cargando…

Determinants of health-related quality of life decline in interstitial lung disease

BACKGROUND: Health-related quality of life (HRQL) in interstitial lung disease (ILD) patients is impaired. We aimed to identify baseline predictors for HRQL decline within a 12-month observation period. METHODS: We analyzed 194 ILD patients from two German ILD-centers in the observational HILDA stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maqhuzu, Phillen Nozibuyiso, Szentes, Boglarka L., Kreuter, Michael, Bahmer, Thomas, Kahn, Nicolas, Claussen, Martin, Holle, Rolf, Schwarzkopf, Larissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542726/ https://www.ncbi.nlm.nih.gov/pubmed/33032602 http://dx.doi.org/10.1186/s12955-020-01570-2

Ejemplares similares

Cost drivers in the pharmacological treatment of interstitial lung disease
por: Maqhuzu, Phillen Nozibuyiso, et al.
Publicado: (2021)

Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
por: Szentes, Boglárka Lilla, et al.
Publicado: (2018)

How does the EQ-5D-5L perform in asthma patients compared with an asthma-specific quality of life questionnaire?
por: Szentes, Boglárka L., et al.
Publicado: (2020)

Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis
por: Wälscher, Julia, et al.
Publicado: (2020)

Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis
por: Schwarzkopf, Larissa, et al.
Publicado: (2018)

Effects of Influenza Vaccination in Patients with Interstitial Lung Diseases: An Epidemiological Claims Data Analysis
por: Marijic, Pavo, et al.
Publicado: (2022)

“Age matters”—German claims data indicate disparities in lung cancer care between elderly and young patients
por: Walter, Julia, et al.
Publicado: (2019)

Effects of Nursing Home Residency on Diabetes Care in Individuals with Dementia: An Explorative Analysis Based on German Claims Data
por: Schwarzkopf, Larissa, et al.
Publicado: (2017)

A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial Pneumonia
por: Kirsten, Detlef, et al.
Publicado: (2021)

Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study
por: Kirsch, Florian, et al.
Publicado: (2019)

Health Care Service Utilization of Dementia Patients before and after Institutionalization: A Claims Data Analysis
por: Schwarzkopf, Larissa, et al.
Publicado: (2014)

A claims data-based comparison of comorbidity in individuals with and without dementia
por: Bauer, Kathrin, et al.
Publicado: (2014)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older population
por: Hunger, Matthias, et al.
Publicado: (2013)

Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2013)

Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study
por: Lutter, Johanna I., et al.
Publicado: (2019)

Predictors of Institutionalization of Dementia Patients in Mild and Moderate Stages: A 4-Year Prospective Analysis
por: Eska, Kathrin, et al.
Publicado: (2013)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2018)

Interstitial lung disease:  course report
por: Kreuter, Michael, et al.
Publicado: (2020)

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
por: Kreuter, Michael, et al.
Publicado: (2019)

Determinants of adherence and effects on health-related quality of life after myocardial infarction: a prospective cohort study
por: Krack, Gundula, et al.
Publicado: (2018)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2016)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2019)

The world of rare interstitial lung diseases
por: Buschulte, Katharina, et al.
Publicado: (2023)

Editorial: Interstitial Lung Disease Around the World
por: Wijsenbeek, Marlies, et al.
Publicado: (2022)

Longitudinal beta regression models for analyzing health-related quality of life scores over time
por: Hunger, Matthias, et al.
Publicado: (2012)

Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2012)

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
por: Kreuter, Michael, et al.
Publicado: (2022)

Fatum Inexorabile: Do Monocytes Predict the Fate of Interstitial Lung Abnormalities?
por: Kreuter, Michael, et al.
Publicado: (2022)

Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
por: Menn, Petra, et al.
Publicado: (2010)

Comorbidities in unclassifiable interstitial lung disease
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
por: Nagy, Alexandra, et al.
Publicado: (2021)

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
por: Kreuter, Michael, et al.
Publicado: (2017)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
por: Marijic, Pavo, et al.
Publicado: (2021)

Comparing outcomes of ILD patients managed in specialised versus non-specialised centres
por: Marijic, Pavo, et al.
Publicado: (2022)

Quality of Life in People With Subjective Cognitive Decline
por: Pavel, Alexandru, et al.
Publicado: (2023)

Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases
por: Bonella, Francesco, et al.
Publicado: (2022)

Nutritional status and quality of life in interstitial lung disease: a prospective cohort study
por: Kanjrawi, Alisar A., et al.
Publicado: (2021)

Health-related quality of life in a multiracial Asian interstitial lung disease cohort
por: Phua, Grace, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djc7bg360jehtp6ch7ugvojid7